Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed <p><em>Scripta Medica</em> is a peer-reviewed and open access journal available in the online and printed form. It covers all fields of medicine, dental medicine, pharmacy and health sciences. <em>Scripta Medica</em> is being published quarterly, by the end of each quarter. The journal has the International Advisory Board with memebers from all over the world.</p> en-US <span>Authors who publish with this journal agree to the following terms:</span><br /><ol type="a"><br /><li>Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a <a href="http://creativecommons.org/licenses/by/3.0/" target="_new">Creative Commons Attribution License</a> that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.</li><br /><li>Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.</li><br /><li>Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See <a href="http://opcit.eprints.org/oacitation-biblio.html" target="_new">The Effect of Open Access</a>).</li></ol> mpstojiljkovic@gmail.com (Miloš P. Stojiljković) slavica.serdar.janjus@med.unibl.org (Slavica Serdar Janjuš) Wed, 29 Apr 2026 15:29:33 +0200 OJS 3.1.2.0 http://blogs.law.harvard.edu/tech/rss 60 Effect of Deuterated Aspirin Treatment of Obese Iraqi Patients With Blood Hyperviscosity Syndrome https://aseestant.ceon.rs/index.php/scriptamed/article/view/63803 <p class="Els-body-text" style="text-indent: 0mm; line-height: 115%;"><strong><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-GB;">Background/Aim: </span></strong><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-GB;">Hyperviscosity syndrome (HVS) is a predictor of blood flow resistance and blood viscosity, density, or thickness. A number of factors that influence blood viscosity have been identified. This study aimed to compare the effects of the deuterated aspirin (aspirin-D) to standard aspirin (aspirin-H) on the prothrombin time (PT) and the normalised international ratio (INR) in obese HVS patients and healthy individuals of normal weight. Haematocrit (HCT) was the primary determinant of blood viscosity and flow resistance.</span></p> <p class="Els-body-text" style="text-indent: 0mm; line-height: 115%;"><strong><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-GB;">Methods:</span></strong><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-GB;"> The study included 120 Iraqi individuals, aged between 21 and 55 years, divided into 2 groups, 60 patients in an obese HVS group and 60 in a healthy weight control group. Total complete blood count, haemoglobin (Hb), the effects of aspirin-H and aspirin-D on blood viscosity were evaluated by measuring HCT, red blood cell (RBC), PT and INR.</span></p> <p class="Els-body-text" style="text-indent: 0mm; line-height: 115%;"><strong><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; color: black; mso-themecolor: text1; mso-ansi-language: EN-GB;">Results:</span></strong><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; color: black; mso-themecolor: text1; mso-ansi-language: EN-GB;"> Patients aged 31&ndash;41 years with a body mass index (BMI) of 30&ndash;39.9 kg/m&sup2; constituted the largest proportion of the HVS group (41.66 %), while the same age group represented the highest percentage among healthy controls (40 %). Patients with HVS showed highly significant increases (p &lt; 0.001) in anthropometric and haematological parameters, including BMI, Hb, HCT and RBC, along with a significant reduction in PT and INR compared to controls. Aspirin treatment, particularly deuterated aspirin, significantly increased PT and INR values, indicating improved anticoagulant activity.</span></p> <p class="Els-body-text" style="text-indent: 0mm; line-height: 115%;"><strong><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; color: black; mso-themecolor: text1; mso-ansi-language: EN-GB;">Conclusion:</span></strong><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-GB;"> <span style="color: black; mso-themecolor: text1;">Aspirin-D was superior to standard aspirin-H in reducing blood viscosity and delaying clotting time in both HVS patients and healthy subjects.</span></span></p> Sura Q Al-Kinany, Fatin Fadhel Mohammed Al-Kazazz, Hussein Inayah, Wasan AM Al Taie Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/63803 Wed, 29 Apr 2026 11:56:35 +0200 Determinants of Health-Related Quality of Life in Mothers of Children With Autism Spectrum Disorder in Bangladesh https://aseestant.ceon.rs/index.php/scriptamed/article/view/64966 <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Background/Aim:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;"> Autism spectrum disorder (ASD) has a significant impact on the quality of life of children with this disorder as well as their mothers. ASD prevalence in Bangladesh has been estimated to be 0.15-0.8 %, but the health-related quality of life (HRQoL) of mothers having children with ASD has not been studied. This study aimed to estimate the HRQoL of these mothers and the main determinants that affect it. </span></p> <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Methods:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;"> This study adopted a cross-sectional design using the SF-scale among 160 mothers who were selected through two stage sampling technique (stratified random and purposive sampling) attending at 16 service centres for persons with disabilities from January to June 2023. </span></p> <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Results:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;"> The mean age of the participants was 32.78 years and they were mostly married (95 %), were Muslims (84.4 %) and only had primary education (29.4 %). The average monthly family income was 17,781 Bangladeshi Taka (BDT). The total HRQoL was significantly low (37.70 &plusmn;18.27). The physical component score (40.32 &plusmn; 21.36) and the mental component score (35.08 &plusmn; 15.17) revealed that there were severe deficits. The findings also suggest that the maternal age, less education, less income, family structure, children age and child-behaviour issues were all significant predictors of poorer HRQoL (p &lt; 0.05). </span></p> <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Conclusions</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">: This paper thus concludes that the HRQoL of the mothers of children with ASD in Bangladesh is critically impaired, due to the effect of socio-economic, family and child related factors. </span></p> Md Mahmudul Hasan, Md Shahjahan, ABM Alauddin Chowdhury, Sanjida Nawrin, Monnuza Rahman, Md Arifur Rahman, Kazi Jonayed Ahmed, Subeer Debnath, Ukraching Marma Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/64966 Wed, 29 Apr 2026 11:58:00 +0200 Anticancer Activity of Opuntia Cochenillifera Extract Against Triple-Negative Breast Cancer Cells via Apoptosis Induction and Bioinformatics-Based Target Prediction https://aseestant.ceon.rs/index.php/scriptamed/article/view/64158 <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 115%;"><strong><span lang="EN-GB" style="mso-ansi-language: EN-GB;">Background/Aim:</span></strong><span lang="EN-GB" style="mso-ansi-language: EN-GB;"> Breast cancer remains one of the most commonly diagnosed cancers among women worldwide and is a significant public health concern. Aim of this study was to investigate the <em>in vitro</em> anticancer activity of <em>Opuntia cochenillifera</em> ethanolic extract (EOC) against triple‑negative breast cancer (TNBC) cells and to predict potential molecular targets involved in its mechanism of action through bioinformatics analysis.</span></p> <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 115%;"><strong><span lang="EN-GB" style="mso-ansi-language: EN-GB;">Methods:</span></strong><span lang="EN-GB" style="mso-ansi-language: EN-GB;"> Fresh <em>O cochenillifera leaves</em> were extracted by ethanol maceration. Phytochemical constituents were analysed using qualitative screening, thin‑layer chromatography (TLC), UV&ndash;Vis spectrophotometry and Fourier transform infrared (FTIR) spectroscopy. Cytotoxicity against MDA‑MB‑231 TNBC cells was determined via MTT assay and morphological assessment. Apoptosis induction was quantified by Annexin V&ndash;FITC/PI flow cytometry. Potential molecular targets were identified through integrated bioinformatics platforms, including <em>STITCH, SEA, SwissTargetPrediction</em>, <em>STRING</em> and <em>Cytoscape</em>, followed by pathway enrichment analysis.</span></p> <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 115%;"><strong><span lang="EN-GB" style="mso-ansi-language: EN-GB;">Results:</span></strong><span lang="EN-GB" style="mso-ansi-language: EN-GB;"> Phytochemical analysis revealed the presence of alkaloids, flavonoids, phenolics, saponins and steroids, with flavonoids as predominant constituents (68 mg/g extract). FTIR spectra confirmed hydroxyl, aliphatic, aromatic and carbonyl functional groups consistent with phenolic and flavonoid structures. EOC exhibited dose‑dependent cytotoxicity against MDA‑MB‑231 cells, with an IC₅₀ of 270.63 &micro;g/mL, accompanied by morphological and flow‑cytometric evidence of apoptosis. Network pharmacology analysis identified 34 apoptosis‑related target genes, including six hub genes (CDKN1A/p21, TP53, MAPK1, MAPK3, AKT1 and FOXO3), associated with TP53‑p21 signalling, MAPK cascades and mitochondrial stress‑induced apoptosis pathways.</span></p> <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 115%;"><strong><span lang="EN-GB" style="mso-ansi-language: EN-GB;">Conclusion:</span></strong><span lang="EN-GB" style="mso-ansi-language: EN-GB;"> <em style="mso-bidi-font-style: normal;">O cochenillifera</em> ethanolic extract demonstrated significant cytotoxic and pro‑apoptotic effects in TNBC cells, potentially mediated through TP53‑p21 and MAPK pathway modulation. These findings suggest that <em style="mso-bidi-font-style: normal;">O cochenillifera</em> is a promising candidate for further investigation as a natural adjuvant therapeutic agent for triple‑negative breast cancer.</span></p> Ali Akbar Alaydrus, Hasan Shodiq Alaydrus, Adilah Assegaf Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/64158 Wed, 29 Apr 2026 11:59:32 +0200 Role of Lung Ultrasound in Determining the Endpoint of Fluid Therapy in Patients With Septic Shock https://aseestant.ceon.rs/index.php/scriptamed/article/view/65172 <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; text-justify: inter-ideograph; line-height: 115%; background: white;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;">Background/Aim:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;"> Fluid resuscitation in septic shock is essential, but determining the optimal volume remains challenging. </span><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-color-alt: windowtext; background: #FCFCFC; mso-ansi-language: EN-GB;">This research aimed to evaluate the role of lung ultrasound (</span><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;">LUS)</span><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-color-alt: windowtext; background: #FCFCFC; mso-ansi-language: EN-GB;"> in assessment of endpoint of fluid therapy in septic shock.</span></p> <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; text-justify: inter-ideograph; line-height: 115%; background: white;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;">Methods:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;"> This prospective observational research comprised 60 adults with septic shock </span><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: SimSun; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;">admitted to critical care unit between May 2024 and December 2025. </span><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;">Fluid responsiveness was assessed by left ventricular outflow tract velocity&ndash;time integral (LVOT VTI) variation during passive leg raise; &ge; 10 % increase defined responders. LUS was performed using simplified, quantitative eight zone and qualitative eight zone protocols. </span><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB; mso-bidi-language: AR-EG; mso-bidi-font-weight: bold;">Echocardiographic evaluation of left ventricular systolic and diastolic function, along with inferior vena cava collapsibility index (IVCCI), was also performed.</span></p> <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; text-justify: inter-ideograph; line-height: 115%; background: white;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;">Results:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;"> Thirty-five patients (58.3 %) were fluid responders and 25 (41.7 %) non-responders. Non-responders exhibited lower IVCCI and higher prevalence of diastolic dysfunction, particularly grades II&ndash;III. The simplified LUS score (cut-off &ge; 11) showed excellent discrimination of fluid unresponsiveness [AUC 0.913 (95 % CI 0.844 &ndash; 0.983)]. The quantitative 8-zone score (cut-off &ge; 4) had good performance [AUC 0.834 (95 % CI 0.732 &ndash; 0.942)], while the qualitative protocol had the highest specificity for discriminating fluid unresponsiveness (sensitivity 76 %, specificity 85.5 %). Combining LUS with echocardiography improved identification of patients unlikely to benefit from further fluid.</span></p> <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; text-justify: inter-ideograph; line-height: 115%; background: white;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;">Conclusion</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-color-alt: windowtext; mso-ansi-language: EN-GB;">: LUS, particularly the simplified protocol, may serve as a bedside tool to predict fluid unresponsiveness and guide resuscitation endpoints in septic shock. Combined with echocardiography, it supports a multimodal, individualised approach that minimises overload risk. </span></p> Walaa Salah Eldeen Mohammed, Tarek Elsayed Gouda, Afaf Abdel Hafez, Mostafa Elmansy, Samar Abd El-Hamid Mousa Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/65172 Wed, 29 Apr 2026 12:01:19 +0200 Prevalence and Associated Factors of Depression in Women in the Last Trimester of Pregnancy: A Cross-Sectional Study in a Southern Province of Vietnam https://aseestant.ceon.rs/index.php/scriptamed/article/view/64810 <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; line-height: 115%;"><strong style="mso-bidi-font-weight: normal;"><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Background/Aim:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;"> Depression during pregnancy is a significant public health issue, particularly in the third trimester when women experience various physical and emotional changes. This study aimed to investigate the prevalence of depression and anxiety among women in the final trimester of pregnancy, as well as the associated factors.</span></p> <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Methods:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;"> <span style="mso-bidi-font-weight: bold;">A cross-sectional descriptive study was conducted involving pregnant women in their last three months of pregnancy who attended regular prenatal check-ups at the prenatal clinic of Phuong Chau International Hospital in Can Tho. The Edinburgh Postnatal Depression Scale (EPDS) was used to screen for depressive symptoms.</span></span></p> <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Results:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;"> The present study found a prevalence of depression of 14.3 %. Symptoms of depression were significantly associated with a history of previous miscarriage (p = 0.004), a history of abortion (p &lt; 0.001), treatment for vulvovaginitis (p = 0.002) and satisfaction with the marital relationship (p = 0.003).</span></p> <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Conclusion:</span></strong><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;"> This study identified factors associated with depressive symptoms<span style="mso-bidi-font-weight: bold;"> in pregnant women during their third trimester. Absence of previous miscarriage, absence of abortion history, no treatment for vulvovaginitis and marital satisfaction were associated with lower odds of depressive symptoms.</span></span></p> Khai Quang Huỳnh, Le Minh Quan Dong, Tai Nang Tran, Quach Giang My Nguyen, Thanh Nam Truong, Phuc Lam Duong, Thi Gai Le Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/64810 Wed, 29 Apr 2026 12:03:10 +0200 Allocation of Stem Cell Alterations in Spermatogenesis of Male Rats Affected by Zymafluor and Detection of Reverse Effect of Vitamin E on Testis Histology Using Immunohistochemical Techniques https://aseestant.ceon.rs/index.php/scriptamed/article/view/65024 <p class="MsoNormal" style="text-align: justify; text-justify: kashida; text-kashida: 0%;"><strong>Background/Aim:</strong> <em>Zymafluor</em> is a proven protective agent against dental caries and it is a naturally occurring agent present in water and soil. Aim of this study was to analyse the detrimental effect of sodium fluoride and opposing effect of vitamin E on spermatogenesis on testicular tissue of male rats using stem cell markers (aldehydes dehydrogenase 1A1 - ALDH1A1 and NANOG).</p> <p class="MsoNormal" style="text-align: justify; text-justify: kashida; text-kashida: 0%;"><strong>Methods:</strong> Four groups of male rats (10 rats in each) were used in this study as follow: group C regarded as a control group received normal saline, group F received sodium fluoride (<em>Zymafluor</em>) once daily, group FE received vitamin E followed by sodium fluoride and group E received vitamin E. The experiment was carried out for 28 days. After this period, the rats were sacrificed and the tissue of testis was processed for immunohistochemistry to stain with ALDH1A1 and NANOG stem cell biomarkers.</p> <p class="MsoNormal" style="text-align: justify; text-justify: kashida; text-kashida: 0%;"><strong>Results:</strong> A decrease in the expression of both ALDH1A1 and NANOG stem cell markers in group F was highly observed and statistically significant. The expression was improved in spermatic cells of group FE for both markers. Normally strong intensity of markers was observed in group E. The spermatogenesis was diminished in F group according to Jonhson score and improved in group FE, while group C and E displayed normal Johnson score for spermatogenesis.</p> <p class="MsoNormal" style="text-align: justify; text-justify: kashida; text-kashida: 0%;"><strong>Conclusion:</strong> Sodium fluoride had a toxic effect on testis affecting spermatogenesis and decreasing quality and quantity of mature sperm, but the administration of vitamin E reversed the toxic effect of sodium fluoride, acting as an antidot. ALDH1A1 and NANOG appeared as markers of stem cell expressed in spermatogenic niche and spermatocytes and affected by many chemicals destroying these cells such as sodium fluoride.</p> Khalida I Noel, Muna Z Al-Hamdany, Sameh S Akkila, Nibras H Khamees Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/65024 Wed, 29 Apr 2026 12:13:37 +0200 The Effect of Gingival Inflammation on Salivary Cytochrome P450 Enzymes in Children: A Case-Control Study https://aseestant.ceon.rs/index.php/scriptamed/article/view/63279 <p style="margin: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB;">Background/Aim<strong><span style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi;">: </span></strong></span></strong><span lang="EN-GB" style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB;">Gingival inflammation in children involves characteristic changes of the salivary composition that reflect not only weakened local defence factors but also increased defensive reflexes. This study aimed to compare the salivary parameters cytochrome concentration, density and flow rate between children with gingival inflammation and clinically healthy gingiva. </span></p> <p style="margin: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB;">Methods: </span></strong><span lang="EN-GB" style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB;">A total of </span><span lang="EN-GB" style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB;">86 children were included and divided into two groups: 41 with gingival inflammation and 45 with healthy gingiva, which was gender matched for age. Unstimulated saliva was collected and cytochrome concentration, salivary density and flow rate were measured. </span></p> <p style="margin: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB;">Results: </span></strong><span lang="EN-GB" style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB;">Participants with gingival inflammation had significantly lower mean salivary cytochrome concentration and density but showed increased salivary flow rate compared to healthy controls. These differences were found in both sexes, being more marked in boys with respect to the age increase of flow rate. Correlation studies showed a strong negative correlation between salivary density and flow rate in both groups. These results indicate that there is a unique biochemical signature for gingival inflammation in children, which includes lower cytochrome and density, accompanied by an increase in flow rate.</span></p> <p style="margin: 0mm; text-align: justify; line-height: 115%;"><strong><span lang="EN-GB" style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB;">Conclusion: </span></strong><span lang="EN-GB" style="mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB;">In children, gingival inflammation was associated with reduced salivary CYP450 and density and increased flow rate in saliva, suggesting a unique biochemistry of oral disease.</span></p> Nada Radhi, Heba N Yassin, Ban Diab Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/63279 Wed, 29 Apr 2026 12:14:59 +0200 Pharmacovigilance and Adverse Drug Reactions in Type 2 Diabetes Mellitus: Insights from a Tertiary Care Hospital in Central India https://aseestant.ceon.rs/index.php/scriptamed/article/view/60113 <p class="MsoNormal" style="text-align: justify; line-height: normal; margin: 6.0pt 0in 6.0pt 0in;"><strong><span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">Background:</span></strong> <span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">Type 2 Diabetes Mellitus is a chronic condition that frequently necessitates prolonged pharmacological treatment and is frequently complicated by polypharmacy and comorbid conditions. These components elevate the likelihood of adverse drug reactions that demand active pharmacovigilance to enhance drug safety and patient adherence.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: normal; margin: 6.0pt 0in 6.0pt 0in;"><strong><span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">Methods: </span></strong><span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">A prospective observational study was carried out over duration of 12 months at a tertiary care teaching hospital located in Central India. A total of 964 adults diagnosed with type 2 diabetics&nbsp;were enrolled. Data on demographics, comorbidities, and drug prescriptions were recorded. ADRs were identified through clinical evaluation and assessed for causality, severity, and preventability. Chi-square tests and logistic regression were utilized for statistical evaluation.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: normal; margin: 6.0pt 0in 6.0pt 0in;"><strong><span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">Results: </span></strong><span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">Among 964 patients (mean age 46.9 &plusmn; 12.4 years), the highest prevalence was observed in the 41&ndash;50 age group (32.6%). ADRs were reported in 231 patients (23.96%). Hypoglycemia (notably with sulfonylureas, p &lt; 0.01) and gastrointestinal disturbances (mainly with metformin) were the most common ADRs. The Naranjo assessment categorized 62.3% of ADRs as probable, with 89.1% classified as mild-to-moderate in severity. According to Schumock and Thornton criteria, 54.5% of ADRs were preventable. Logistic regression revealed polypharmacy (OR = 2.73, p &lt; 0.01) and</span> <span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">kidney dysfunction (OR = 2.21, p &lt; 0.01) as significant predictors of ADRs.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: normal; margin: 6.0pt 0in 6.0pt 0in;"><strong><span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">Conclusion: </span></strong><span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">This research underscores a significant prevalence of ADRs&nbsp;in patients with T2DM, with many being preventable. Sulfonylureas and metformin were frequently implicated. Strengthening pharmacovigilance practices and promoting rational drug use are necessary for improving patient safety and therapeutic results in diabetes management.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: normal; margin: 6.0pt 0in 6.0pt 0in;"><strong><span style="font-size: 14.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman';">&nbsp;</span></strong></p> Rajveer Singh Rathore, Akash Vishwe, Susheel Kumar, Lokendra Sharma, Alka Bansal, Punam Jakhar Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/60113 Wed, 29 Apr 2026 12:16:07 +0200 Co-Crystals for Drug Design: A Logical Approach for Modifying Physicochemical Properties of Drugs https://aseestant.ceon.rs/index.php/scriptamed/article/view/60064 <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify;"><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB;">Drug design plays a critical role in the pharmaceutical industry, addressing the limitations of many compounds with medicinal properties that cannot serve as an effective active pharmaceutical ingredient. Extensive research has been conducted to overcome this challenge, with co-crystals emerging as a promising solution. In drug design, APIs often face challenges such as low solubility, poor mechanical properties, or degradation risks. Since the discovery of co-crystals, their potential applications have expanded significantly. Initially recognised as simple solubility modifiers, recent research emphasises their diverse uses, including flavour masking and the enhancement of mechanical properties. With the commercialisation of co-crystal-based drugs, research has shifted from their potential applications to optimise production methods. This article reviews key production methods, including solvent evaporation and hot-melt extrusion, which enable scalable and ecologically sustainable co-crystal synthesis. Addressing poor physicochemical properties, especially low bioavailability, remains a persistent challenge in pharmaceutical development. Co-crystals present an innovative and efficient solution</span><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">. </span><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB;">An active pharmaceutical ingredient (API) and a co-former are joined by non-covalent interactions to form co-crystals, which are crystalline solids. These structures maintain the natural pharmacological efficacy of pharmaceuticals while improving their physicochemical characteristics, such as stability and solubility. They provide a systematic and rational approach to improve API properties because their design follows well-established crystal engineering principles. This review emphasises the increasing interest in co-crystals and their importance in crystal preparation methods. Co-crystallisation has improved the stability, dissolution rate and solubility of active pharmaceutical ingredients. Although, there are challenges related to scalability, innovative solutions are necessary to ensure consistent and cost-effective production. With ongoing research and advancements in scalable manufacturing, co-crystals are poised to revolutionise pharmaceutical development by overcoming bioavailability challenges and enhancing therapeutic outcomes.</span></p> Punam Gaba, Mona Piplani, Shailesh Sharma Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/60064 Wed, 29 Apr 2026 12:17:17 +0200 Phytochemical Heterocycles in Depression Management: A Sustainable Strategy https://aseestant.ceon.rs/index.php/scriptamed/article/view/60299 <p class="Abstract"><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; mso-bidi-font-family: 'Times New Roman'; color: windowtext; mso-ansi-language: EN-GB;">According to WHO, depression is raising globally and expected as global burden by 2030. After COVID-19, drastic incline led to 17 % of total world population that suffered from well-known mental disorder depression and around 140,000 suicides annually attributed to depression. Owing to the diverse adverse effects associated with marketed antidepressants, research has increasingly shifted towards traditional herbal medicines for curing the both physical and emotional symptoms associated with depression. In recent years, natural products, particularly plant-derived secondary metabolites have with heterocyclic backbones, has become promising candidates for depression therapy. This review explores the medicinal potential of various plant-based compounds, including indole alkaloid, pyridine alkaloid, saponins, polyphenols. The secondary metabolites of these plants have demonstrated markable antidepressant-like effects in preclinical studies by modulating neurotransmitter system, reducing inflammation and promoting neurogenesis. For instance, compounds such as psychollatine and mitragynine (indole alkaloid), saikosaponin (saponins) and polyphenolic compounds like crocin and curcumin have resultant biological activity. Herbal remedies like St John&rsquo;s Wort (<em>Hypericum perforatum</em>), saffron, turmeric and ginseng have been used from centuries for mood regulation. By combining traditional knowledge with modern scientific researches, researchers can utilise the nature&rsquo;s therapeutic power to innovate safer and effective treatments for depression. However, further investigation is necessary to elucidate the accurate mechanism of these compounds through which they exert their effect, optimise dosing, quality control and rigorous clinical trials. Ultimately, by combining the best of both traditional medicine and modern science- there can be revolution in the treatment of depression and lives of countless individuals can be improved.</span></p> Harmanbir Kaur, Tejinder Kaur Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/60299 Wed, 29 Apr 2026 12:18:25 +0200 Ubiquitously Occurring Perfluoroalkyl and Polyfluoroalkyl Substances: An Overview of Food and Environmental Contamination and Implications for Human Health https://aseestant.ceon.rs/index.php/scriptamed/article/view/64908 <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; line-height: normal;"><span lang="EN-GB" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Perfluoroalkyl and polyfluoroalkyl substances (PFAS), commonly known as &lsquo;forever chemicals&rsquo;, are synthetic, anthropogenic compounds widely used in food packaging, processing equipment and nonstick surfaces. Their strong carbon&ndash;fluorine bonds make them highly persistent in the environment and within living organisms, including humans. This review focuses on the chemical structures of PFAS, their similarity to fatty acids, environmental contamination pathways, their entry into the food chain and water systems, their biological behaviour and their adverse health effects. Our observations suggest that the harmful effects of PFAS pollutants may be even more far-reaching, as they may jeopardise the function of the cardiorespiratory, neurological and reproductive systems in humans. PFAS analogues exhibit exceptionally long biological half-lives in humans with 2.7 to 5.1 years for perfluorooctanoic acid (PFOA), 3.4 to 5.7 years for perfluorooctane sulfonate (PFOS) and 2.8 to 8.5 years for perfluorohexane sulfonate (PFHxS)<span style="color: #ee0000;">, </span>often persisting in blood and tissues for several years after exposure has ceased. This prolonged retention allows PFAS to accumulate over time, increasing the likelihood of chronic exposure and long-term health consequences even at low environmental concentrations. Evidence-based regulations by food and environmental regulatory agencies, along with projections of the impacts of regulatory intervention, are needed to protect public health. </span></p> Poonam Jaglan, Harpal S Buttar, Douglas W Wilson, Istvan G Telessy Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/64908 Wed, 29 Apr 2026 12:41:35 +0200 A Narrative Review on Preclinical/Clinical Trials on Aducanumab https://aseestant.ceon.rs/index.php/scriptamed/article/view/59386 <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify; text-justify: inter-ideograph;"><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB;">The most widespread type of dementia, Alzheimer's disease (AD), is predicted to triple in global prevalence by 2050. AD has a substantial societal and economic impact across the world, negatively affecting both patients and their caregivers, as the disorder has few therapeutic alternatives. Aducanumab was the first monoclonal antibody approved in 2021 for the treatment of mild AD. Representing the first AD drug approval in 20 years and based on the concept of targeting amyloid-&beta; (A&beta;) as an immunisation treatment for AD, Aducanumab was demonstrated to reduce A&beta; plaque formation in animal models and humans. This was used as a proxy of efficacy in AD clinical trials to slow disease progression and reduce cognitive decline in AD. Culminating from the A&beta; hypothesis of AD that has dominated the focus of AD drug development since its inception, Aducanumab, for many, represents validation of the hypothesis and promise for the future. This review examines the antibody research, preclinical and clinical studies, that underpin the development of aducanumab as an AD medication. No single drug is generally likely to cure a complex, progressive and heterogeneous degenerative disorder, but it may act as a stepping stone towards greater understanding and potentially more effective treatment options. Time will ultimately tell in the case of aducanumab as to whether it is a small or large step in the correct or incorrect direction to unravel the mystery of this complex disorder and provide a worthwhile treatment. </span></p> Akriti Goel, Garima, Paras Jain, Seema Bansal, Hitesh Chopra, Sumeet Gupta, Satish Kumar, Meenakshi Dhanawat, Navidha Aggarwal Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/59386 Wed, 29 Apr 2026 12:42:44 +0200 Emerging Biomaterial Strategies for Giant Cell Arteritis: Challenges and Future Outlook https://aseestant.ceon.rs/index.php/scriptamed/article/view/60209 <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 115%;"><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Giant cell arteritis (GCA) is a common vasculitis of the big arteries that affects people as they get older and it usually results in potentially serious problems like vision loss and stroke. Steroids remain the cornerstone of GCA treatment, although long-term steroid use is associated with significant adverse effects and a high chance of recurrence. This review will look at biomaterials as a new treatment technique that could help improve GCA management through focused therapy, reduced systemic side effects and facilitated vascular restoration. A comprehensive evaluation of current breakthroughs in biomaterial-based GCA techniques was carried out, with an emphasis on nanoparticles, hydrogels and tissue-engineered scaffolds. The literature was reviewed to determine their therapeutic efficacy, biocompatibility and potential for clinical use. Biomaterials such as nanoparticles and hydrogels have showed promise in controlled drug delivery, allowing for focused treatment at sick artery sites while lowering systemic steroid exposure. Tissue-engineered scaffolds have shown promise for vascular repair and regeneration, at least more effectively than standard methods of treating an injured vessel. However, many problems exist, including maintaining long-term biocompatibility, stability and avoiding immunological responses. Although early preclinical studies have produced encouraging results, clinical translation is still in its infancy. Emerging biomaterials will be a potential area in GCA care, offering new opportunities for treatment efficacy enhancement while reducing side effects. Advanced research in the areas of biocompatibility and immune response challenges should be conducted to ease these promising tactics into clinical practice as a new hope for people suffering from this debilitating condition. </span></p> Bhavani Sowndharya Balamurugan, Vickram Agaram Sundaram, Mathan Muthu Chinnakannu Marimuthu, Saravanan Anbalagan, Hitesh Chopra Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/60209 Wed, 29 Apr 2026 12:43:57 +0200 Pathophysiological Pathways Linking Diabetes to Cardiac Hypertrophy: From Insulin Resistance to Personalised Cardioprotection https://aseestant.ceon.rs/index.php/scriptamed/article/view/60346 <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify;"><span lang="EN-GB" style="font-family: 'Times New Roman',serif;">Diabetes and cardiac hypertrophy are closely interconnected, sharing overlapping metabolic and cardiovascular pathways. This review aimed to investigate the underlying mechanisms that drive this relationship and to evaluate current diagnostic and therapeutic strategies with the goal of improving clinical outcomes. An extensive review of recent literature was undertaken to explore how factors such as insulin resistance, hyperglycaemia, inflammation, oxidative stress and lipotoxicity contribute to cardiac remodelling and functional decline. Developments in diagnostic modalities, including advanced imaging techniques and emerging biomarkers, were examined alongside both lifestyle interventions and pharmacological treatments. Diabetes is a significant contributor to the progression of cardiac hypertrophy, primarily through metabolic dysregulation and persistent low-grade inflammation. The importance of early detection&mdash;using sophisticated imaging tools and biomarker profiling&mdash;has become increasingly evident for timely and effective intervention. Therapeutic agents such as metformin, sodium glucose cotransporter-2 inhibitors (SGLT2) and glucagon like peptide-1 receptor agonist (GLP-1) have demonstrated beneficial effects in reducing cardiovascular complications in individuals with diabetes. Moreover, novel approaches, including chronotherapy and personalised medicine, are gaining traction as potential means to enhance treatment efficacy and patient outcomes. The robust association between diabetes and cardiac hypertrophy underscores the necessity for a more integrated and nuanced approach to diagnosis and management. Combining early detection with targeted pharmacotherapy and personalised care strategies offers a promising route to addressing this complex clinical challenge. Continued research is essential to refine these approaches and to optimise long-term outcomes for affected patients.</span></p> Gaurav Joshi, NIshant Goutam, Shivani Shivani, Kanika Kaushal, Abhishashi Sharma, Harmanbir Kaur, Neeraj Joshi Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/60346 Wed, 29 Apr 2026 12:45:11 +0200 Antifungal Interventions and Clinical Outcomes: A Review https://aseestant.ceon.rs/index.php/scriptamed/article/view/58699 <p class="MsoNormal" style="text-align: justify; margin: 6.0pt 0mm 0mm 0mm;"><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-GB;">Fungal infections pose a significant risk to public health since they are linked to high rates of illness and death, particularly in immunocompromised individuals. Therapy is difficult because there are few antifungal drugs available and many of them are harmful. Fungi have also evolved defence mechanisms to fight these drugs. This article overlooks at antifungal drugs that are currently on the market, discusses resistance mechanisms and investigates new treatment-enhancing strategies. Combinations of antifungal drugs can increase effectiveness and reduce toxicity. New drug formulations, including nanoparticles are being studied to improve dispersion and reduce adverse effects. Furthermore, commercially marketed prescriptions may become more effective if their chemical makeup is changed. Additionally, novel drugs are being tested more rapidly and precisely using mini-host animal models. These creative methods could expedite the process and enhance patient outcomes. This study notes multiple challenges, such as patient peculiarities, intricate drug interactions and pathogen diversity, while also emphasising the advancements in antifungal therapy. Enhancing efficacy and reducing toxicity requires advancements in diagnosis, treatment and medicine. More studies on emerging fungal infections and antibiotic resistance are needed.</span></p> Simran Simran, Punam Gaba, Neelam Sharma, Jeewanjot Singh Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/58699 Wed, 29 Apr 2026 12:46:28 +0200 Unveiling the Therapeutic Potential of Ipomoea Batatas Lam: A Journey From Preclinical Research to Clinical Applications https://aseestant.ceon.rs/index.php/scriptamed/article/view/59248 <p class="MsoNormal" style="text-align: justify; line-height: 115%;"><em><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Ipomoea batatas</span></em><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;"> Lam, commonly known as sweet potato, has garnered recognition for its significant therapeutic potential, which can be largely ascribed to its abundant array of bioactive secondary metabolites. Among these phytoconstituents, flavonoids, anthocyanins, carotenoids and terpenoids have been shown to possess notable pharmacological properties through preclinical investigations. Evidence from <em>in vitro</em> studies utilising cell culture models indicates that these compounds exhibit robust antioxidant and anticancer activities, with anthocyanins in particular being reported to inhibit the proliferation of cancer cells. Furthermore, <em>in vivo</em> experiments substantiate the diverse therapeutic efficacy of <em>Ipomoea batatas</em>, revealing its anti-obesity, hypoglycaemic, hepatoprotective and anti-arthritic properties. Advancements in the understanding of these therapeutic attributes have facilitated the progression of extracts from <em>Ipomoea batatas</em> to clinical evaluation with subsequent assessment of safety, toxicity, pharmacokinetics and benefit-risk ratios. The transition from preclinical research to clinical validation accentuates its relevance in the realm of metabolic health, especially in combating obesity, liver dysfunction and diabetes. The successful completion of Phase III clinical trials has resulted in the introduction of plant-based antidiabetic formulations into the market, thereby reinforcing the pharmacological significance of this plant. Nevertheless, despite these promising developments, the complex interactions between the phytoconstituents and their corresponding therapeutic effects warrant further investigation. Continued research in this domain is essential, as it promises not only to enrich the understanding of the medicinal properties of <em>Ipomoea batatas</em> but also to reveal innovative therapeutic applications. Such endeavours will likely establish <em>Ipomoea batatas</em> as an esteemed natural resource within contemporary&nbsp;medicine.</span></p> Riya Singla, Sonia Kamboj, Brijesh Kumar Duvey, Anurag Bhargava, Jasmine Chaudhary, Akash Jain Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/59248 Wed, 29 Apr 2026 12:47:38 +0200 Global Research Trends and Risk Factors for Loneliness in Older Adults https://aseestant.ceon.rs/index.php/scriptamed/article/view/60482 <p class="MsoNormal" style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: Times, serif; text-indent: 36pt;"><span lang="EN-US" style="font-size: 12pt; font-family: 'Times New Roman', serif;">Loneliness was defined as an unpleasant feeling for a person when there is a gap between expectations of desired social connection with actual number of social relationships owned, both in terms of quantity or especially the quality. This research was systematic literature review with bibliometric analysis employs a two-phase quantitative approach. In the first phase, scientific publications were collected from two databases, there is Scopus and Web of Science (WoS). The analysis and visualization show that loneliness among older adults is an increasingly prominent topic in global research, especially since the COVID-19 pandemic. This research reveals that loneliness was closely linked to multidimensionality and was receiving attention from various fields, including neuroscience, behavioral health and geriatric care. The main themes of this research include psychological and cognitive factors, social isolation, and geriatric vulnerability.</span></p> <p class="MsoNormal" style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: Times, serif;"><span lang="EN-US" style="font-size: 12pt; font-family: 'Times New Roman', serif;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Although the topic of loneliness among the elderly is gaining high attention in global academic interest, there was still a gap in innovative research, which calls for a multidisciplinary approach, especially in the discussion of risk factors for loneliness among the elderly. Some of the potential topics for further research are the relationship of loneliness among the elderly with socioeconomic factors, technology and digitalization, elderly care, religion and culture, and the direct relationship of loneliness with biomedical risks in geriatric clinical conditions such as atrial fibrillation, cognitive impairment, osteoporosis, and fall risk. These topics will open up great opportunities for researchers to contribute to and develop the advancement of this issue.</span></p> Riskita Ayudira Salsabila, Vernonia Yora Saki, Ahmad Azmi Nasution, Rizkianti Anggraini, Onetusfifsi Putra Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/60482 Wed, 29 Apr 2026 12:48:56 +0200 Gunshot Wound: Pathogenesis https://aseestant.ceon.rs/index.php/scriptamed/article/view/65829 <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify;"><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-fareast-language: RU;">Gunshot wounds remain one of the most complex types of <a name="_Hlk217044269"></a>combat injuries. A gunshot wound is a dynamic system in which the initial mechanical destruction of tissue is only the starting point of a complex and multi-level process. </span><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Subsequently, the wound site steadily transforms and the volume of non-viable tissue increases, spreading beyond the wound channel area. This review examines the pathogenesis of a gunshot wound, which is a chain of cause-and-effect changes in which each link is formed as a direct consequence of previous disturbances. The pathophysiological <a name="_Hlk217904492"></a>events that contribute to the chronic wound process are identified, which cannot be interrupted by natural mechanisms.</span></p> Vitaliy Makarov, Sergey Pavlov, Rostislav Shevchenko, Volodymyr Feskov, Marina Kumetchko, Oleksii Petiunin, Dmytro Myroshnychenko, Nataliia Babenko, Olga Litvinova Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/65829 Wed, 29 Apr 2026 12:50:07 +0200 COVID-19 Vaccine Safety in Adults: A Narrative Review of Adverse Reactions in ASEAN Countries https://aseestant.ceon.rs/index.php/scriptamed/article/view/60151 <p class="MsoNormal" style="text-align: justify; line-height: 115%; mso-pagination: widow-orphan;"><span lang="EN-GB" style="font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-GB;">The spread of the SARS-CoV-2 virus, known as the COVID-19 virus, which causes the coronavirus disease 2019 known as &ldquo;COVID-19&rdquo;, has led to a rapid response from governments around the world. In response to the significant threat it presents to global health, comprehensive strategies have been implemented to mitigate worldwide transmission and reduce mortality rate. Association of South East Asian Nations (ASEAN) countries have also taken steps to encourage people to get vaccinated. The use of vaccines from many global pharmaceutical companies has led to the collection of reports on adverse drug reactions to monitor and evaluate the use of pharmaceutical products after administrated. This study aimed to evaluate the adverse drug reactions of COVID-19 vaccines administered in ASEAN countries through a narrative review of relevant scientific literature. A narrative review was conducted using <em>PubMed </em>and <em>ScienceDirect </em>databases to identify original, open-access studies published between 2020 and 2025. Eligible articles involved adults aged 18&ndash;59 years and reported adverse events following COVID-19 vaccination in ASEAN countries. Nine studies met the inclusion criteria and were qualitatively analysed. Six vaccines were evaluated: Ad26.COV2.S (<em>Johnson &amp;Johnson</em>), AZD1222 (<em>AstraZeneca</em>), BNT162b2 (<em>Pfizer-BioNTech</em>), CoronaVac (<em>Sinovac</em>), Sputnik V and mRNA-1273 (<em>Moderna</em>). The most adverse drug reactions reported included injection site pain, fever, headache, fatigue and muscle pain, respectively, based on the severity of side effects. Current evidence confirms that COVID-19 vaccines used in Southeast Asian demonstrated favourable safety and tolerability profiles among adults, consistent with global pharmacovigilance data. These findings support continued vaccination programs and highlight the importance of strengthening regional pharmacovigilance systems and harmonised AEFI reporting to sustain public confidence in immunisation efforts across ASEAN.<span style="mso-tab-count: 1;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p> Prasti Andini, Endang Darmawan, Anhar Muflih, Muhammad Ridwan Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/60151 Wed, 29 Apr 2026 12:51:23 +0200 Case Series of Burkholderia Pseudomallei Infections in Critically Ill Patients: Unveiling Key Challenges https://aseestant.ceon.rs/index.php/scriptamed/article/view/60050 <p class="MsoNormal" style="margin-bottom: 0mm; text-align: justify;"><span lang="EN-GB" style="font-family: 'Times New Roman',serif; mso-ansi-language: EN-GB;">Melioidosis remains a diagnostic challenge in tropical regions due to its broad clinical spectrum. This series presents seven diabetic individuals from an endemic area with diverse forms of the disease, including pulmonary, visceral, soft tissue and lymph node involvement. Laboratory confirmation was achieved through culture and nested polymerase chain reaction (PCR). Most patients improved with appropriate intravenous therapy followed by oral antibiotics; one experienced recurrence. The varied presentations often resemble other endemic infections, delaying diagnosis. Prompt clinical recognition and early use of molecular tools are vital for initiating targeted treatment and improving outcomes in vulnerable populations.</span></p> Rishwanth Raja, Baby K Sailaja, RV Hemalatha, Velmurugan Selvam, MK Renuka Copyright (c) 2026 Scripta Medica https://aseestant.ceon.rs/index.php/scriptamed/article/view/60050 Wed, 29 Apr 2026 12:52:52 +0200